NYSE · PEN
Penumbra, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for PEN: Nov 4, 2026
Penumbra, Inc. Common Stock is estimated to report earnings on 11/04/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $0.97.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Fintel · RTTNews · Zacks · BNK Invest- Fintel · Oct 30, 2:28 AM EDTPenumbra, Inc. Reports Third Quarter 2026 Revenue of $410.1 millionPenumbra, Inc. reported revenue of $410.1 million for the third quarter of 2026, representing an increase of 15.6% compared to the third quarter of 2025. The company's global thrombectomy revenue reached $279.2 million, up 18.1% compared to the same period in the prior year, driv
- RTTNews · Oct 29, 4:15 PM EDTPenumbra Inc. Q3 Income Drops(RTTNews) – Penumbra Inc. (PEN) released a profit for third quarter that Dropped, from the same period last year
- Zacks · Oct 1, 10:40 AM EDTIART vs. PEN: Which Stock Is the Better Value Option?IART vs. PEN: Which Stock Is the Better Value Option?
- Zacks · Sep 29, 10:40 AM EDTIART or PEN: Which Is the Better Value Stock Right Now?IART vs. PEN: Which Stock Is the Better Value Option?
- Zacks · Sep 16, 9:13 AM EDTReasons to Retain Penumbra Stock in Your Portfolio for NowPEN's portfolio expansion and international growth support momentum, while rising costs, FX exposure and margin pressure remain key risks.
- Zacks · Sep 11, 11:40 AM EDTTFX vs. PEN: Which Stock Is the Better Value Option?TFX vs. PEN: Which Stock Is the Better Value Option?
- BNK Invest · Aug 26, 3:19 PM EDTNotable Wednesday Option Activity: ZVRA, KOD, PENLooking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Zevra Therapeutics, Inc (Symbol: ZVRA), where a total volume of 8,827 contracts has been traded thus far today, a contract volume which is representative of appr
- Zacks · Aug 26, 11:40 AM EDTTFX or PEN: Which Is the Better Value Stock Right Now?TFX vs. PEN: Which Stock Is the Better Value Option?
- Zacks · Aug 6, 2:16 PM EDTIs ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising costs and execution risks keep the buy case uncertain.
- RTTNews · Jul 30, 4:33 PM EDTPenumbra Inc. Q2 Income Falls(RTTNews) – Penumbra Inc. (PEN) announced a profit for second quarter that Dropped, from last year
- MarketBeat · Jul 20, 9:40 AM EDT3 Medical Device Stocks Giving Investors a Different Healthcare PlayWhen investors think of the health care sector, most imagine the stability of pharmaceutical giants or the high-risk/high-reward profile of up-and-coming clinical stage drug developers. Medical device companies operate within a unique ecosystem and are often easy to overlook. Th
- Zacks · Jul 14, 11:40 AM EDTIQV vs. PEN: Which Stock Is the Better Value Option?IQV vs. PEN: Which Stock Is the Better Value Option?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Penumbra, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.